Legal status · United States
Is GLOW capsules legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. GLOW capsules is not an approved medicine in the United States; its classification is "Not approved; research use only". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 2 human studies are cited on its profile.
GLOW capsules in the United States at a glance
| Classification | Not approved; research use only |
|---|---|
| Note | Marketed as a supplement; BPC-157 was placed on FDA's list of substances that present significant safety risks for compounding, and is not a lawful dietary ingredient. |
| FDA approval status | Not approved as a drug. Sold as a supplement despite containing peptides FDA has placed outside the compounding lists, which is a regulatory position vendors assert rather than one a regulator has granted. |
| Human studies cited | 2 of 5 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the GLOW capsules profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
No product containing GLOW capsules is approved by FDA for any use in the United States, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in the United States. This page is general information, not legal advice.
What GLOW capsules is
The injectable skin blend sold as a swallowed capsule, typically 2 mg GHK-Cu, 500 micrograms each of BPC-157 and TB-500, and 100 mg of hyaluronic acid. The combination has never been tested by any route, and the oral route has never been tested for any of the three peptides. By mass the capsule is about 97% hyaluronic acid.
Oral versions of the copper blends appeared once needles became the obstacle to a wider market. The formula per capsule is usually 2 mg GHK-Cu, 500 micrograms of BPC-157, 500 micrograms of the fragment sold as TB-500, and 100 mg of hyaluronic acid.
Mechanism: Unknown by this route. The mechanisms claimed are the topical and injected mechanisms of the components: copper delivery and collagen signalling for GHK-Cu, repair pathway activity for BPC-157, actin binding for the fragment.
Regulatory history: Not approved as a drug. Sold as a supplement despite containing peptides FDA has placed outside the compounding lists, which is a regulatory position vendors assert rather than one a regulator has granted.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for GLOW capsules at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
GLOW capsules in other countries
Frequently asked questions
Is GLOW capsules legal in the United States?
No. GLOW capsules is not an approved medicine in the United States; its classification is "Not approved; research use only". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 2 human studies are cited on its profile. Note: Marketed as a supplement; BPC-157 was placed on FDA's list of substances that present significant safety risks for compounding, and is not a lawful dietary ingredient.
Can I buy GLOW capsules in the United States?
No approved product exists to buy. In the United States GLOW capsules is classified as "Not approved; research use only", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: Marketed as a supplement; BPC-157 was placed on FDA's list of substances that present significant safety risks for compounding, and is not a lawful dietary ingredient.
Is GLOW capsules FDA approved?
No. FDA status: Not approved as a drug. Sold as a supplement despite containing peptides FDA has placed outside the compounding lists, which is a regulatory position vendors assert rather than one a regulator has granted.. Current US classification: "Not approved; research use only". On the evidence, 2 human studies are cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for GLOW capsules live on its compound profile.
GLOW capsules profileThis page is general information about the regulatory status of GLOW capsules in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.